Tarik ElAmrani

Center for Sarcoma & BoneOncology/Dana ...Boston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

Phase III Open-label Study of Nilotinib Versus Imatinib in GIST Patients
March 2009 - May 2021
Gastrointestinal Stromal Tumors
Nilotinib (Amn107)
Imatinib (Sti571)



